VoxNeuro is ready to change the way brain health is managed and treated across the globe. Today’s cognitive assessments are reliant on subjective measures like patient self-reporting and observed behaviour, opening the door for faulty results. The types of brain health assessments using objective measures that are available today, such as MRI or CT, only scan for structural issues (e.g. lesions in brain tissue, brain bleeds, or damage to the skull) and cannot provide an understanding of a brain’s cognitive health.
Enter VoxNeuro. The Canadian neuroscience and health tech company has developed a 30-minute, non-invasive Cognitive Health Assessment that uses electroencephalography (EEG) to record tens of thousands of data-points from a patient’s brain waves while they perform a series of tasks on a computer. The company’s medical software, the Cognitive Health Assessment Management Platform (CHAMP), then rapidly analyzes, transforms and compares the patient data to a database of healthy cognitive function. This is a procedure similar to that used with MRI and CT scans, which compares a patient’s brain structure to a healthy brain structure database. The result of VoxNeuro’s assessment is a report that objectively scores the patient’s cognitive function in the areas of attention and concentration, information processing, and memory.
With its success in southern Ontario, VoxNeuro now seeks to continue scaling across North America. This fall, the company launched in the USA through a network of diagnostic imaging centers in New York state. It will also soon be deploying at the first of many neurology clinics in the south-eastern United States where its assessment will become available in the next 12 months.
VoxNeuro plans to be operational in approximately 100 clinics in North America by the end of 2022.
Read the full Canadian Healthcare Technology article here